Korea’s one and only biotechnology engineering and construction company, capable of providing a comprehensive range of services from consultation and design to construction, inspection and auditing, and maintenance
GCEM, at the time of its foundation Korea’s only engineering and construction company specializing in biotechnology facilities, has been growing at an astonishing pace since its establishment in 2001. The company continues to lead the biotechnology facility construction market, having successfully built production and research facilities conforming to GMP and Bio-Safety Level (BSL) certification requirements.
GCEM built GC Ochang, the largest GMP-certified pharmaceutical plant in Korea, as well as GC Hwasun, Korea’s exclusive influenza vaccination production facility. In 2013, the company also successfully completed the construction of a new research facility on par with BSL 4 for the Korea Centers for Disease Control, once again proving its position as the leader and pioneer in the Korean biotech construction market.